Prospective evaluation of 20G core needle for EUS-guided histology of pancreatic tumor

Prospective evaluation of 20G core needle for EUS-guided histology of pancreatic tumor - Prospective evaluation of 20G core needle for EUS-guided histology of pancreatic tumor

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000022813

Enrollment

Registered

2016-06-22

Start date

2016-06-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic neoplasm

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Pancreatic tumor in size >10mm 2) age >20

Exclusion criteria

Exclusion criteria: 1) Performance status 4 2) Pregnant woman 3) Platelet count <50,000/mm3 4) PT-international normalized ratio >1.5 or

Design outcomes

Primary

Measure	Time frame
Quality of histology	—

Secondary

Measure	Time frame
The accuracy rate of histology and cytology, The success rate of EUS-FNA, Feasibility of immunohistochemical analysis, the incidence of adverse events	—

Countries

Japan

Contacts

Public ContactHirotoshi Ishiwatari

Shizuoka Cancer Center Division of Endoscopy

ishihiro481019@gmail.com055-989-5222

Outcome results